Internal Medicine, Medical Oncology · Mountain View, CA
NPI
1407889827
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
701 E El Camino Real
Mountain View, CA, 94040
Phone (650) 934-7600
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.8M
1,260 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rosendo So-Rosillo prescribed most often to Medicare patients was Abiraterone Acetate, with 243 prescriptions and refills. In total Rosendo So-Rosillo wrote 1,260 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 243 | 422 | 55 | $60K |
| Prednisone Generic | 207 | 536 | 71 | $1,846 |
| Anastrozole Generic | 77 | 243 | 25 | $2,247 |
| Hydroxyurea Generic | 56 | 117 | 14 | $2,335 |
| Nivestym Filgrastim-Aafi | 55 | 55 | 15 | $36K |
| Xtandi Enzalutamide | 50 | 50 | Under 11 | $610K |
| Dexamethasone Generic | 39 | 50 | 30 | $827 |
| Ondansetron Hcl Generic | 37 | 41 | 24 | $292 |
| Potassium Chloride Generic | 27 | 49 | Under 11 | $615 |
| Granix Tbo-Filgrastim | 26 | 26 | Under 11 | $19K |
| Oxycodone Hcl Generic | 25 | 25 | 13 | $450 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | 13 | $518 |
| Lynparza Olaparib | 18 | 18 | Under 11 | $286K |
| Ondansetron Odt Ondansetron | 17 | 17 | Under 11 | $207 |
| Inlyta Axitinib | 17 | 17 | Under 11 | $261K |
Brand drugs: - claims; generic drugs: 976 claims; opioid claims: 55.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rosendo So-Rosillo were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.